Jefferies Reiterates Buy Rating on Lava Therapeutics NV (LVTX) Following Earnings, 'LAVA 1266 tracking to 2Q24 IND submission'
Tweet Send to a Friend
Jefferies analyst Roger Song reiterated a Buy rating and $6.00 price target on Lava Therapeutics NV (NASDAQ: LVTX).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
